NRXPW 8-K 2026-06-04
NRX Pharmaceuticals, Inc. (NRXPW) 8-K dated 2026-06-04 — accession 0001437749-26-019576. This URL is the filing, not the NRXPW hub.
NRX Pharmaceuticals, Inc. (NRXPW) common stock listed on NASDAQ.
NRX Pharmaceuticals, Inc. filed a 8-K on 2026-06-04. Accession 0001437749-26-019576.
Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Not investment advice. The NRXPW SEC hub lists recent forms. The stock page is the research view.